These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18205672)

  • 1. Occult hepatitis B infection in blood donors.
    Reesink HW; Engelfriet CP; Henn G; Mayr WR; Delage G; Bernier F; Krusius T; Assal A; Gallian P; Corbi C; Morel P; David B; De Micco P; Murokawa H; Yugi H; Hino S; Tadokoro K; Flesland O; Brojer E; Letowska M; Olim G; Nascimento F; Gonçalves H; Castro L; Morais M; Stezinar SL; Alvarez M; Sauleda S; González R; Niederhauser C; Stolz M; Allain JP; Owusu-Ofori S; Eglin R; Stramer S; Busch M; Strong DM; Epstein J; Biswas R
    Vox Sang; 2008 Feb; 94(2):153-66. PubMed ID: 18205672
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascertaining the prevalence of occult hepatitis B virus infection in voluntary blood donors: a study from Central India.
    Punde RP; Bhargava A; Varshney S; Pathak N; Shrivastava M; Mishra PK
    Indian J Pathol Microbiol; 2011; 54(2):408. PubMed ID: 21623110
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
    J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening.
    Allain JP
    Vox Sang; 2007 Apr; 92(3):254-7. PubMed ID: 17348876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatitis B virus deoxyribonucleic acid using real-time polymerase chain reaction method in pooled-plasma samples of Turkish blood donors.
    Karakoc AE; Berkem R; Beyaz E
    Clin Lab; 2009; 55(5-6):229-34. PubMed ID: 19728557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis in HIV infection.
    Leiner S
    N Engl J Med; 2007 Jul; 357(1):90; author reply 91. PubMed ID: 17615640
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection.
    Zaaijer HL; Torres P; Ontañón A; Ponte LG; Koppelman MH; Lelie PN; Hemert FJ; Boot HJ
    J Med Virol; 2008 Aug; 80(8):1344-9. PubMed ID: 18551607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor.
    Manzini P; Abate ML; Valpreda C; Milanesi P; Curti F; Rizzetto M; Smedile A
    Transfusion; 2009 Apr; 49(4):757-64. PubMed ID: 19171000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission.
    El-Zayadi AR; Ibrahim EH; Badran HM; Saeid A; Moneib NA; Shemis MA; Abdel-Sattar RM; Ahmady AM; El-Nakeeb A
    Transfus Med; 2008 Feb; 18(1):55-61. PubMed ID: 18279193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients.
    Demir M; Serin E; Göktürk S; Ozturk NA; Kulaksizoglu S; Ylmaz U
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):668-73. PubMed ID: 18679070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B is not necessarily an infection.
    Shorbagi A; Bayraktar Y
    J Clin Gastroenterol; 2008 Oct; 42(9):1064-5. PubMed ID: 18431247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progresses in the molecular diagnosis of hepatitis B viral infection].
    Panait M; Oprişan G; Codiţă I
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period.
    Wendel S; Levi JE; Biagini S; Candotti D; Allain JP
    Transfusion; 2008 Aug; 48(8):1602-8. PubMed ID: 18466175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.
    Candotti D; Grabarczyk P; Ghiazza P; Roig R; Casamitjana N; Iudicone P; Schmidt M; Bird A; Crookes R; Brojer E; Miceli M; Amiri A; Li C; Allain JP
    J Hepatol; 2008 Oct; 49(4):537-47. PubMed ID: 18602718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which level of immunosuppression is harmful for occult hepatitis B virus infection?
    Ozaslan E
    Liver Int; 2009 Aug; 29(7):1126-7; author reply 1127-8. PubMed ID: 19453947
    [No Abstract]   [Full Text] [Related]  

  • 19. Occult hepatitis B in blood donors: a description of two cases.
    Capezzuto C; Franchi E; Urbani S; Romanò L; Franchini M
    Blood Transfus; 2010 Oct; 8(4):297-302. PubMed ID: 20967173
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of various minipool nucleic acid test systems for hepatitis B virus detection in blood donors.
    Grabarczyk P; Letowska M; Kopacz A; Liszewski G; Sulkowska E; Brojer E
    Transfusion; 2009 Jul; 49(7):1494-5. PubMed ID: 19602212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.